Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mirela Vatic

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Experimental Gerontology|February 3, 2020
Inflammatory biomarkers of frailtyMirela Vatic, Stephan von Haehling, Nicole Ebner
Expert Opinion on Pharmacotherapy|October 22, 2024
Pharmacological management of heart failure: a patient-centred approachGuglielmo Fibbi, Ryosuke Sato, Mirela Vatic, et al.
Current Heart Failure Reports|October 19, 2022
Sarcopenia and Frailty in Heart Failure: Is There a Biomarker Signature?Ryosuke Sato, Mirela Vatic, Guilherme Wesley Peixoto da Fonseca, et al.
Cardiovascular Research|June 3, 2024
Biological basis and treatment of frailty and sarcopeniaRyosuke Sato, Mirela Vatic, Guilherme Wesley Peixoto da Fonseca, et al.
Journal of Cachexia, Sarcopenia and Muscle|January 16, 2026
Skeletal Muscle Mass Modifies the Prognostic Impact of LDL Cholesterol in Chronic Heart FailureRyosuke Sato, Tania Garfias-Veitl, Guglielmo Fibbi, et al.
European Journal of Heart Failure|February 13, 2023
Bone status in men with heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart FailureGoran Loncar, Tania Garfias-Veitl, Miroslava Valentova, et al.
Diabetes Research and Clinical Practice|September 20, 2024
Diabetes mellitus is associated with low exercise capacity and impaired peripheral vasodilation in patients with heart failure - a propensity score-matched studyMiroslava Valentova, Mirela Vatic, Tania Garfias-Veitl, et al.
Aging Cell|November 15, 2025
Different Pattern in Circulating MicroRNA-22-3p Levels Between Patients With Primary Versus Secondary SarcopeniaMirela Vatic, Anselm A Derda, Tania Garfias-Veitl, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Experimental Gerontology|February 3, 2020
Inflammatory biomarkers of frailtyMirela Vatic, Stephan von Haehling, Nicole Ebner
Expert Opinion on Pharmacotherapy|October 22, 2024
Pharmacological management of heart failure: a patient-centred approachGuglielmo Fibbi, Ryosuke Sato, Mirela Vatic, et al.
Current Heart Failure Reports|October 19, 2022
Sarcopenia and Frailty in Heart Failure: Is There a Biomarker Signature?Ryosuke Sato, Mirela Vatic, Guilherme Wesley Peixoto da Fonseca, et al.
Cardiovascular Research|June 3, 2024
Biological basis and treatment of frailty and sarcopeniaRyosuke Sato, Mirela Vatic, Guilherme Wesley Peixoto da Fonseca, et al.
Journal of Cachexia, Sarcopenia and Muscle|January 16, 2026
Skeletal Muscle Mass Modifies the Prognostic Impact of LDL Cholesterol in Chronic Heart FailureRyosuke Sato, Tania Garfias-Veitl, Guglielmo Fibbi, et al.
European Journal of Heart Failure|February 13, 2023
Bone status in men with heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart FailureGoran Loncar, Tania Garfias-Veitl, Miroslava Valentova, et al.
Diabetes Research and Clinical Practice|September 20, 2024
Diabetes mellitus is associated with low exercise capacity and impaired peripheral vasodilation in patients with heart failure - a propensity score-matched studyMiroslava Valentova, Mirela Vatic, Tania Garfias-Veitl, et al.
Aging Cell|November 15, 2025
Different Pattern in Circulating MicroRNA-22-3p Levels Between Patients With Primary Versus Secondary SarcopeniaMirela Vatic, Anselm A Derda, Tania Garfias-Veitl, et al.
Pageof 1